NCT03322098View on ClinicalTrials.gov

Effect of Atropine or Glycopyrrolate on the Prevention of Bradycardia During Sedation Using Dexmedetomidine in Geriatric Patients Undergoing Total Knee Replacement Under Spinal Anesthesia

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

October 16, 2017

Primary Completion Date

May 15, 2018

Study Completion Date

May 15, 2018

Conditions
Spinal Anesthesia
Interventions
DRUG

Atropine

Atropine injection (0.01 mg/kg, max 0.5 mg) within 3 minutes before spinal anesthesia

DRUG

Glycopyrrolate

Glycopyrrolate (0.00 4mg/kg, max 0.2 mg) within 3 minutes before spinal anesthesia

Trial Locations (1)

03722

Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT03322098 - Effect of Atropine or Glycopyrrolate on the Prevention of Bradycardia During Sedation Using Dexmedetomidine in Geriatric Patients Undergoing Total Knee Replacement Under Spinal Anesthesia | Biotech Hunter | Biotech Hunter